| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Vol. 143, No. 9: 889-897
Copyright © 1996 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Low Levels of Sex Hormone-binding Globulin and Testosterone Predict the Development of Non-Insulin-dependent Diabetes Mellitus in Men
1Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio San Antonio, TX
2Multiple Risk Factor Intervention Trial Coordinating Center, Division of Biostatistics, School of Public Health, University of Minnesota Minneapolis, MN
3Department of Public Health, University of Glasgow Glasgow, Scotland
4Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh Pittsburgh, PA
Reprint requests to Jessica Shaten, University of Minnesota School of Public Health, MRFIT Coordinating Center, 2221 University Avenue S.E., Suite 200, Minneapolis, MN 55414
Few prospective data are available regarding the association of sex hormone-binding globulin (SHBG), testosterone, and the risk of developing diabetes. Stored fasting serum samples from participants enrolled in the Multiple Risk Factor Intervention Trial (MRFIT) at 22 different centers throughout the United States from December 1973 through February 1976 were used to perform a nested case-control study. For 176 initially nondiabetic men who developed diabetes during 5 years of follow-up, two controls were selected, one matched only for randomization date, treatment group, and clinic ("loose controls") and the other matched additionally for fasting glucose and body mass index ("tight controls"). When cases were compared with loose controls, higher levels of fasting insulin and lower levels of total and free testosterone and SHBG were significantly associated with increased development of diabetes. However, when cases were compared with tightly matched controls, these associations weakened considerably. Low SHBG and testosterone may constitute part of the prediabetic state in men along with previously reported variables, such as higher glucose and insulin levels and obesity. Am J Epidemiol 1996;143:889–97.
diabetes mellitus; insulin; prasterone; sex hormone-binding globulin; testosterone
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. M. Lakshman, S. Bhasin, and A. B. Araujo Sex Hormone-Binding Globulin as an Independent Predictor of Incident Type 2 Diabetes Mellitus in Men J Gerontol A Biol Sci Med Sci, January 27, 2010; (2010): glq002v1 - glq002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chamson-Reig, S. M. Thyssen, D. J. Hill, and E. Arany Exposure of the Pregnant Rat to Low Protein Diet Causes Impaired Glucose Homeostasis in the Young Adult Offspring by Different Mechanisms in Males and Females Exp Biol Med, December 1, 2009; 234(12): 1425 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Patel, S. J. Ratcliffe, M. P. Reilly, R. Weinstein, S. Bhasin, M. R. Blackman, J. A. Cauley, K. Sutton-Tyrrell, J. Robbins, L. P. Fried, et al. Higher Serum Testosterone Concentration in Older Women is Associated with Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4776 - 4784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Coviello, S. Sam, R. S. Legro, and A. Dunaif High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4361 - 4366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I Hackett, N. S Cole, A. A Deshpande, M. D Popple, D. Kennedy, and P. Wilkinson Biochemical hypogonadism in men with type 2 diabetes in primary care practice The British Journal of Diabetes & Vascular Disease, September 1, 2009; 9(5): 226 - 231. [Abstract] [PDF]
|
|
|
|
 |
|
 F Bonnet, B Balkau, J M Malecot, P Picard, C Lange, F Fumeron, R Aubert, V Raverot, H Dechaud, J Tichet, et al. Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels Eur. J. Endocrinol., July 1, 2009; 161(1): 81 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Theodoraki and P.-M. Bouloux Testosterone therapy in men Menopause Int, June 1, 2009; 15(2): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Traish, F. Saad, and A. Guay The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance J Androl, January 1, 2009; 30(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R D Stanworth, D Kapoor, K S Channer, and T H Jones Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes Eur. J. Endocrinol., December 1, 2008; 159(6): 739 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Yassin and F. Saad Testosterone and Erectile Dysfunction J Androl, November 1, 2008; 29(6): 593 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Murtola, T. L. J. Tammela, J. Lahtela, and A. Auvinen Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study Am. J. Epidemiol., October 15, 2008; 168(8): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kupelian, F. J. Hayes, C. L. Link, R. Rosen, and J. B. McKinlay Inverse Association of Testosterone and the Metabolic Syndrome in Men Is Consistent across Race and Ethnic Groups J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3403 - 3410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Basaria Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth J Androl, September 1, 2008; 29(5): 534 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kapoor, K. S Channer, and T H. Jones Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 135 - 137. [Abstract] [PDF]
|
|
|
|
|
|
S. Shahani, M. Braga-Basaria, and S. Basaria Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2042 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kasturi, J. Tannir, and R. E. Brannigan The Metabolic Syndrome and Male Infertility J Androl, May 1, 2008; 29(3): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Darbinian, A. M. Ferrara, S. K. Van Den Eeden, C. P. Quesenberry Jr., B. Fireman, and L. A. Habel Glycemic Status and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 628 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Fritz, A. J.S. McKean, J. C. Nelson, and R. B. Wilcox Analog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations Clin. Chem., March 1, 2008; 54(3): 512 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-T. Khaw, M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, R. Luben, A. Welch, and N. Day Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation, December 4, 2007; 116(23): 2694 - 2701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Yialamas, A. A. Dwyer, E. Hanley, H. Lee, N. Pitteloud, and F. J. Hayes Acute Sex Steroid Withdrawal Reduces Insulin Sensitivity in Healthy Men with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4254 - 4259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hall, S. T. Page, T. G. Travison, R. B. Montgomery, C. L. Link, and J. B. McKinlay Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1587 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kapoor, H. Aldred, S. Clark, K. S. Channer, and T. H. Jones Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity Diabetes Care, April 1, 2007; 30(4): 911 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Selvin, M. Feinleib, L. Zhang, S. Rohrmann, N. Rifai, W. G. Nelson, A. Dobs, S. Basaria, S. H. Golden, and E. A. Platz Androgens and Diabetes in Men: Results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care, February 1, 2007; 30(2): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Tande, E. A. Platz, and A. R. Folsom The Metabolic Syndrome Is Associated with Reduced Risk of Prostate Cancer Am. J. Epidemiol., December 1, 2006; 164(11): 1094 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, M. Noda, S. Tsugane, and for the Japan Public Health Center-Based Prospecti Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med, September 25, 2006; 166(17): 1871 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Kapoor, E Goodwin, K S Channer, and T H Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol., June 1, 2006; 154(6): 899 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Ding, Y. Song, V. S. Malik, and S. Liu Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis JAMA, March 15, 2006; 295(11): 1288 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kupelian, S. T. Page, A. B. Araujo, T. G. Travison, W. J. Bremner, and J. B. McKinlay Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 843 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Pitteloud, V. K. Mootha, A. A. Dwyer, M. Hardin, H. Lee, K.-F. Eriksson, D. Tripathy, M. Yialamas, L. Groop, D. Elahi, et al. Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men Diabetes Care, July 1, 2005; 28(7): 1636 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford and S. Liu Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life? Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106. [Full Text] [PDF]
|
|
|
|
|
|
N. Pitteloud, M. Hardin, A. A. Dwyer, E. Valassi, M. Yialamas, D. Elahi, and F. J. Hayes Increasing Insulin Resistance Is Associated with a Decrease in Leydig Cell Testosterone Secretion in Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2636 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Phillips Is Atherosclerotic Cardiovascular Disease an Endocrinological Disorder? The Estrogen-Androgen Paradox J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2708 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, and J. T. Salonen The Metabolic Syndrome and Smoking in Relation to Hypogonadism in Middle-Aged Men: A Prospective Cohort Study J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodriguez, A. V. Patel, A. M. Mondul, E. J. Jacobs, M. J. Thun, and E. E. Calle Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men Am. J. Epidemiol., January 15, 2005; 161(2): 147 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Page, K. L. Herbst, J. K. Amory, A. D. Coviello, B. D. Anawalt, A. M. Matsumoto, and W. J. Bremner Testosterone Administration Suppresses Adiponectin Levels in Men J Androl, January 1, 2005; 26(1): 85 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Liu, R. S. Swerdloff, and J. D. Veldhuis The Rationale, Efficacy and Safety of Androgen Therapy in Older Men: Future Research and Current Practice Recommendations J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4789 - 4796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, R. Salonen, and J. T. Salonen Testosterone and Sex Hormone-Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men Diabetes Care, May 1, 2004; 27(5): 1036 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance: Influence of sex hormone-binding globulin and body fat Diabetes Care, April 1, 2004; 27(4): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cousin, L. Calemard-Michel, H. Lejeune, G. Raverot, N. Yessaad, A. Emptoz-Bonneton, Y. Morel, and M. Pugeat Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 917 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhasin, A. B. Singh, R. P. Mac, B. Carter, M. I. Lee, and G. R. Cunningham Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan J Androl, May 1, 2003; 24(3): 299 - 311. [Full Text] [PDF]
|
|
|
|
|
|
S. Ebrahim, G. D. Smith, M. May, and J. Yarnell Shaving, Coronary Heart Disease, and Stroke: The Caerphilly Study Am. J. Epidemiol., February 1, 2003; 157(3): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Ellison, R. G. Bribiescas, G. R. Bentley, B. C. Campbell, S. F. Lipson, C. Panter-Brick, and K. Hill Population variation in age-related decline in male salivary testosterone Hum. Reprod., December 1, 2002; 17(12): 3251 - 3253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Abate, S. M. Haffner, A. Garg, R. M. Peshock, and S. M. Grundy Sex Steroid Hormones, Upper Body Obesity, and Insulin Resistance J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4522 - 4527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J Gerontol A Biol Sci Med Sci, February 1, 2002; 57(2): M76 - M99. [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study Diabetes Care, January 1, 2002; 25(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Hsing, S. Chua Jr, Y.-T. Gao, E. Gentzschein, L. Chang, J. Deng, and F. Z. Stanczyk Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study J Natl Cancer Inst, May 16, 2001; 93(10): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Michalek, F. Z. Akhtar, and J. L. Kiel Serum Dioxin, Insulin, Fasting Glucose, and Sex Hormone-Binding Globulin in Veterans of Operation Ranch Hand J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1540 - 1543. [Abstract] [Full Text]
|
|
|
|
|
|
D. S. Ooi, J. G. Donnelly, S. J. Winters, D. E. Kelley, and B. Goodpaster More on the Analog Free-Testosterone Assay • The authors of the article cited above respond: Clin. Chem., May 1, 1999; 45(5): 714 - 716. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Winters, D. E. Kelley, and B. Goodpaster The analog free testosterone assay: are the results in men clinically useful? Clin. Chem., October 1, 1998; 44(10): 2178 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Simon, M.-A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 682 - 685. [Abstract] [Full Text] [PDF]
|
|